Glycosaminoglycan catabolic process

pathway activity — cross-omics
GO:0006027Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Glycosaminoglycan catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD209, STAB1, and CD93, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Glycosaminoglycan catabolic process activity versus CD209 in BRCA (Pearson r = 0.32).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACD209 →+0.491+0.141.001.00137
GBMSTAB1 →+1.005+0.267<.001<.00136
GBMCD93 →+0.770+0.270<.001<.00135
OVLILRB5 →+0.559+0.207.002.00535
UCECFAM20A →+0.715+0.155.005.00335
GBMRNASE1 →+0.952+0.176.001.00435
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006027 vs CD209 — BRCA

Per-sample scatter of Glycosaminoglycan catabolic process activity vs CD209 in BRCA.

Explore this scatter interactively →

Exploration